APPLICATION
NDA017546
TYPE
NDA
ORIGINAL APPROVAL
1974-05-10
LATEST ACTION
1990-10-18
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
NIPRIDEDiscontinued
SODIUM NITROPRUSSIDE 50MG/VIAL · INJECTABLE · INJECTION
Approval history
1990-10-18Labeling · Supplement 23AP
1987-05-27Labeling · Supplement 21AP
1985-05-15Labeling · Supplement 12AP
1984-07-30Labeling · Supplement 18AP
1981-02-13Labeling · Supplement 10AP
1979-01-23Labeling · Supplement 9AP
1977-12-27Labeling · Supplement 6AP
1974-05-10Type 1 - New Molecular Entity · Original · priorityAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.